Product/Composition:- | Metronidazole Suspension |
---|---|
Strength:- | 125 mg/5 mL, 250 mg/5 mL, 375 mg/5 mL |
Form:- | Suspension |
Reference Brands:- | Flagyl(US) |
MOQ | As per the manufacturer batch size |
Get Quote Send Enquiry on WhatsApp |
Metronidazole suspension inhibits bacterial and protozoal DNA synthesis by disrupting nucleic acid structures. It effectively treats anaerobic infections, parasitic protozoal diseases, and bacterial vaginosis. Benefits include rapid, targeted eradication of pathogens, good tissue penetration, oral convenience, and safety when used appropriately, making it ideal for outpatient and pediatric treatments.
Metronidazole suspension is approved in the EU and US for pediatric and adult treatment of anaerobic bacterial and protozoal infections. In the EU, brands like Flagyl are regulated by EMA, supported by dossiers demonstrating safety, efficacy, and manufacturing quality. In the US, FDA approval is based on extensive clinical data; generic formulations are available. Both regions require detailed dossiers, including clinical trial results, quality documentation, and pharmacovigilance plans for approval and ongoing safety monitoring. For expert support with regulatory dossiers, compliance, and registration, visit PharmaTradz. We support seamless market access for metronidazole suspension, ensuring adherence to European and US standards for safe, effective antimicrobial therapy.